Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Summit Therapeutics Operating Income 2015-2024 | SMMT

Summit Therapeutics annual/quarterly operating income history and growth rate from 2015 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Summit Therapeutics operating income for the quarter ending June 30, 2024 was $-0.060B, a 277.47% increase year-over-year.
  • Summit Therapeutics operating income for the twelve months ending June 30, 2024 was $-0.159B, a 73.11% decline year-over-year.
  • Summit Therapeutics annual operating income for 2023 was $-0.61B, a 745.69% increase from 2022.
  • Summit Therapeutics annual operating income for 2022 was $-0.072B, a 16.36% decline from 2021.
  • Summit Therapeutics annual operating income for 2021 was $-0.086B, a 62.03% increase from 2020.
  
Summit Therapeutics Annual Operating Income
(Millions of US $)
2023 $-610
2022 $-72
2021 $-86
2020 $-53
2019 $-27
2019 $9
2018 $-17
2017 $-33
2016 $-31
2015 $-21
2014 $-21
2014 $
Summit Therapeutics Quarterly Operating Income
(Millions of US $)
2024-06-30 $-60
2024-03-31 $-42
2023-12-31 $-36
2023-09-30 $-20
2023-06-30 $-16
2023-03-31 $-537
2022-12-31 $-20
2022-09-30 $-17
2022-06-30 $-13
2022-03-31 $-22
2021-12-31 $-26
2021-09-30 $-19
2021-06-30 $-24
2021-03-31 $-17
2020-12-31 $-12
2020-09-30 $-17
2020-06-30 $-15
2020-03-31 $-9
2019-12-31 $-5
2019-10-31 $-10
2019-09-30 $-6
2019-07-31 $-8
2019-04-30 $-6
2019-01-31 $31
2018-10-31 $-12
2018-07-31 $38
2018-04-30 $-9
2018-01-31 $-33
2017-10-31 $-8
2017-07-31 $13
2017-04-30 $-7
2017-01-31 $-31
2016-10-31 $-6
2016-07-31 $-10
2016-04-30 $-9
2016-01-31 $-5
2015-10-31 $-8
2015-07-31 $-8
2015-04-30 $-6
2015-03-31 $-1
2015-01-31 $1
2014-12-31 $-1
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $15.132B $0.001B
Summit Therapeutics PLC is engaged in the discovery and development of drug to treat the fatal muscle wasting disease Duchenne Muscular Dystrophy and infections caused by the bacteria C. difficile. Summit Therapeutics PLC is headquartered in Abingdon, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $88.259B 35.16
Takeda Pharmaceutical (TAK) Japan $46.264B 9.26
Merck (MKGAF) Germany $22.763B 24.84
Astellas Pharma (ALPMY) Japan $21.481B 25.80
Sandoz Group AG (SDZNY) Switzerland $18.033B 0.00
United Therapeutics (UTHR) United States $15.951B 16.48
Shionogi (SGIOY) Japan $13.190B 12.64
Neurocrine Biosciences (NBIX) United States $11.618B 34.76
Catalent (CTLT) United States $10.948B 0.00
Orion OYJ (ORINY) Finland $8.028B 32.69
Revolution Medicines (RVMD) United States $7.378B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.850B 7.26
Ionis Pharmaceuticals (IONS) United States $5.973B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.660B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.612B 0.00
Corcept Therapeutics (CORT) United States $4.590B 38.88
Crinetics Pharmaceuticals (CRNX) United States $4.062B 0.00
Dyne Therapeutics (DYN) United States $3.397B 0.00
PTC Therapeutics (PTCT) United States $2.889B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.535B 14.62
Arrowhead Pharmaceuticals (ARWR) United States $2.445B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.322B 18.45
Recursion Pharmaceuticals (RXRX) United States $1.962B 0.00
Soleno Therapeutics (SLNO) United States $1.910B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.789B 0.00
Xencor (XNCR) United States $1.579B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.576B 0.00
Ardelyx (ARDX) United States $1.566B 0.00
Harrow (HROW) United States $1.564B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.461B 0.00
ARS Pharmaceuticals (SPRY) United States $1.388B 0.00
Indivior (INDV) United States $1.384B 6.35
Cassava Sciences (SAVA) United States $1.367B 0.00
Ocular Therapeutix (OCUL) United States $1.353B 0.00
Evotec AG (EVO) Germany $1.265B 0.00
Collegium Pharmaceutical (COLL) United States $1.233B 7.07
Avadel Pharmaceuticals (AVDL) Ireland $1.227B 0.00
Enliven Therapeutics (ELVN) United States $1.140B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.041B 0.00
Relay Therapeutics (RLAY) United States $0.999B 0.00
Bioventus (BVS) United States $0.943B 30.63
Cronos Group (CRON) Canada $0.830B 0.00
USANA Health Sciences (USNA) United States $0.722B 13.26
Savara (SVRA) United States $0.698B 0.00
Pacira BioSciences (PCRX) United States $0.671B 6.35
Ironwood Pharmaceuticals (IRWD) United States $0.642B 40.20
Tourmaline Bio (TRML) United States $0.641B 0.00
Exscientia (EXAI) United Kingdom $0.612B 0.00
4D Molecular Therapeutics (FDMT) United States $0.563B 0.00
Silence Therapeutics (SLN) United Kingdom $0.546B 0.00
ProKidney (PROK) United States $0.539B 0.00
KalVista Pharmaceuticals (KALV) United States $0.533B 0.00
Foghorn Therapeutics (FHTX) United States $0.518B 0.00
OmniAb (OABI) United States $0.502B 0.00
Siga Technologies (SIGA) United States $0.497B 5.95
Altimmune (ALT) United States $0.460B 0.00
Sage Therapeutics (SAGE) United States $0.445B 0.00
Aquestive Therapeutics (AQST) United States $0.430B 0.00
Xeris Biopharma Holdings (XERS) United States $0.428B 0.00
Verve Therapeutics (VERV) United States $0.421B 0.00
Larimar Therapeutics (LRMR) United States $0.419B 0.00
Elite Pharmaceuticals (ELTP) United States $0.417B 39.00
Theravance Biopharma (TBPH) Cayman Islands $0.396B 0.00
Lyell Immunopharma (LYEL) United States $0.387B 0.00
Organogenesis (ORGO) United States $0.383B 0.00
Zevra Therapeutics (ZVRA) United States $0.364B 0.00
Eliem Therapeutics (ELYM) United States $0.334B 0.00
Esperion Therapeutics (ESPR) United States $0.330B 0.00
Aldeyra Therapeutics (ALDX) United States $0.327B 0.00
Korro Bio (KRRO) United States $0.321B 0.00
Heron Therapeutics (HRTX) United States $0.302B 0.00
Lexeo Therapeutics (LXEO) United States $0.301B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.289B 0.00
ESSA Pharma (EPIX) Canada $0.286B 0.00
Akebia Therapeutics (AKBA) United States $0.280B 0.00
Avita Medical (RCEL) United States $0.279B 0.00
Nature's Sunshine Products (NATR) United States $0.260B 17.77
Corbus Pharmaceuticals Holdings (CRBP) United States $0.252B 0.00
Nanobiotix S.A (NBTX) France $0.251B 0.00
Black Diamond Therapeutics (BDTX) United States $0.239B 0.00
Acrivon Therapeutics (ACRV) United States $0.222B 0.00
Nektar Therapeutics (NKTR) United States $0.215B 0.00
Pyxis Oncology (PYXS) United States $0.215B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.213B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.210B 0.00
Telomir Pharmaceuticals (TELO) United States $0.202B 0.00
CytoDyn (CYDY) United States $0.196B 0.00
Profound Medical (PROF) Canada $0.194B 0.00
MediWound (MDWD) Israel $0.190B 0.00
Innate Pharma SA (IPHYF) France $0.180B 0.00
Galectin Therapeutics (GALT) United States $0.169B 0.00
Achieve Life Sciences (ACHV) Canada $0.164B 0.00
VAXART, INC (VXRT) United States $0.146B 0.00
Cardiol Therapeutics (CRDL) Canada $0.145B 0.00
Context Therapeutics (CNTX) United States $0.140B 0.00
Century Therapeutics (IPSC) United States $0.136B 0.00
Incannex Healthcare (IXHL) Australia $0.128B 0.00
Fractyl Health (GUTS) United States $0.123B 0.00
Journey Medical (DERM) United States $0.119B 0.00
Prelude Therapeutics (PRLD) United States $0.117B 0.00
Assertio Holdings (ASRT) United States $0.113B 19.67
Regulus Therapeutics (RGLS) United States $0.105B 0.00
OptiNose (OPTN) United States $0.105B 0.00
Relmada Therapeutics (RLMD) United States $0.102B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.101B 0.00
Citius Pharmaceuticals (CTXR) United States $0.094B 0.00
CASI Pharmaceuticals (CASI) China $0.093B 0.00
AlloVir (ALVR) United States $0.092B 0.00
Karyopharm Therapeutics (KPTI) United States $0.090B 0.00
Arch Biopartners (ACHFF) Canada $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.083B 0.00
Metagenomi (MGX) United States $0.083B 0.00
PMV Pharmaceuticals (PMVP) United States $0.077B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 370.33
Verrica Pharmaceuticals (VRCA) United States $0.072B 0.00
Nutriband (NTRB) United States $0.067B 0.00
Champions Oncology (CSBR) United States $0.064B 0.00
Vivani Medical (VANI) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.058B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.055B 0.00
Mural Oncology (MURA) Ireland $0.052B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
BioLineRx (BLRX) Israel $0.050B 0.00
Rafael Holdings (RFL) United States $0.047B 0.00
ProPhase Labs (PRPH) United States $0.046B 0.00
ElectroCore (ECOR) United States $0.044B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
Inotiv (NOTV) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
FibroGen (FGEN) United States $0.041B 0.00
DURECT (DRRX) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
Unicycive Therapeutics (UNCY) United States $0.039B 0.00
Protara Therapeutics (TARA) United States $0.039B 0.00
Enlivex Therapeutics (ENLV) Israel $0.035B 0.00
Tempest Therapeutics (TPST) United States $0.035B 0.00
Surrozen (SRZN) United States $0.033B 0.00
Oruka Therapeutics (ORKA) United States $0.028B 0.00
VYNE Therapeutics (VYNE) United States $0.027B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.024B 0.00
Lipocine (LPCN) United States $0.024B 0.00
MEI Pharma (MEIP) United States $0.019B 0.67
TherapeuticsMD (TXMD) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.019B 0.00
NRx Pharmaceuticals (NRXP) United States $0.019B 0.00
Lyra Therapeutics (LYRA) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.017B 0.00
Cosmos Health (COSM) United States $0.016B 0.00
Talphera (TLPH) United States $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Indaptus Therapeutics (INDP) United States $0.013B 0.00
Conduit Pharmaceuticals (CDT) United States $0.012B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
TransCode Therapeutics (RNAZ) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.011B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Plus Therapeutics (PSTV) United States $0.011B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Avalo Therapeutics (AVTX) United States $0.010B 0.00
Aptorum Group (APM) United Kingdom $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Vivos Therapeutics (VVOS) United States $0.009B 0.00
Viracta Therapeutics (VIRX) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
BioVie (BIVI) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Traws Pharma (TRAW) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Oncternal Therapeutics (ONCT) United States $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.10
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (BGM) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.29
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 39.50